|
Market Cap (5-Jun) $15,812,900 (1,318th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 2,106,389 |
Shortsold (23-Jan) 143,231 (0.01%) (538th) |
|
52w High $0.029 |
52w Low $0.010 |
P/E - |
EPS 0 |
NTI released this announcement to the ASX on 17 October 2022, 8:12. The announcement is marked as price sensitive, and is 3 page(s) in length and 187.64kb in size.
You can view all announcements from NTI and see how they appear on a price chart on the announcements page.
At the date of this announcement, NTI was 0.033% short sold according to ASIC data. It was ranked the 567th most shorted stock on the ASX. It is now ranked as the 538th most shorted stock on the ASX with 0.011% of total shares short sold as of the latest reported data (23 January 2026).
| Other Recent Announcements from NTI | |
|---|---|
| Notification of cessation of securities - NTI | 30 June 2023, 17:06 |
| Notification regarding unquoted securities - NTI | 28 June 2023, 16:14 |
| NTI to Present at Rett Syndrome Foundation Meeting | 5 June 2023, 8:27 |
| New Phase I/II Clinical Trial in Children with PANDAS/PANS | 17 October 2022, 8:12 |
| Application for quotation of securities - NTI | 12 October 2022, 19:48 |
| Proposed issue of securities - NTI | 11 October 2022, 17:45 |
| Autism Spectrum Disorder Phase I/II Clinical Trial Update | 15 September 2022, 9:48 |
You must be logged in to post a reply.
Neurotech International 